Matthew Bowen sold $137 of Monte Rosa Therapeutics stock
By AlphaYouPublished Form 4
Bowen Matthew
Reporting filer
Matthew Bowen reported selling 13 shares of Monte Rosa Therapeutics, Inc. for about $137 ($10.56 a share on average). Form 4 filed Oct 6, 2026 lists 1 entry.
See the price move since this trade →
- Disclosed
- Oct 6, 2026
Reported details
1 entry| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Bowen Matthew | 2026-10-05 | S | Sale | 13 | 10.56 | 25,891 | 1 day | Filed terms
|
Common Stock
- Owner
- Bowen Matthew
- Date
- 2026-10-05
- Code
- S
- Action
- Sale
- Quantity
- 13
- Price
- 10.56
- Following holdings
- 25,891
- Reporting delay
- 1 day
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-10-05
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: false
- id: F1
- transaction Shares: 13
- transaction Price Per Share: 10.56
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 25891
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Bowen Matthew: Principal Accounting Officer.
- F1: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales were automatic and not in the discretion of the Reporting Person.
Original sources
Prepared automatically from public filing data. Report a correction.